ANalgesic Efficacy and Safety of MOrphiNe Versus Methoxyflurane in Patients With Acute Myocardial Infarction

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT04476173

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04476173
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Poland (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04476173. Randomized; no masking; primary purpose treatment. Start 2020-06-01 (actual); primary completion 2024-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ANalgesic Efficacy and Safety of MOrphiNe Versus Methoxyflurane in Patients With Acute Myocardial Infarction
Acronym
ANEMON
Condition
ST Elevation Myocardial Infarction
Condition
Non ST Segment Elevation Acute Coronary Syndrome
Intervention (Drug)
Methoxyflurane - Penthrox
Intervention (Drug)
Morphine
Lead sponsor
Collegium Medicum w Bydgoszczy (class: other)

Record details

Record id
cardio:ct-nct04476173
Content hash
6d0cf74d01941e7edd344214e046c314c0cf01fb6acfde072f885f81ce119f18